OCSL earnings analysis
What we found in OCSL's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
OCSL's Q3 FY2026 total investment income declined 7.8% year over year to $69.4 million as lower reference rates reduced portfolio interest income, though a 12.3% decline in net expenses limited the impact on net investment income. Credit indicators improved in non-accruals, but this was overshadowed by $49.5 million of quarterly realized losses and a $106.0 million decline in portfolio fair value since September 2025. Liquidity is adequate with $659.0 million of undrawn facility capacity, but the highly floating-rate portfolio remains vulnerable to further benchmark-rate reductions.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Investment income declined 7.8% year over year
- Total investment income was $69.4 million in Q3 FY2026, down $5.8 million, or 7.8%, from $75.3 million a year earlier, principally because reference-rate declines reduced interest income by $7.6 million.
- Lower funding costs mitigated income pressure
- Expense discipline partly offset the income decline: net expenses fell $5.1 million, or 12.3%, to $36.6 million, driven primarily by $6.9 million lower interest expense from lower reference rates and lower average borrowings.
- Non-accrual exposure improved
- Credit quality improved on a non-accrual count basis. Six investments were on non-accrual at June 30, 2026, representing 1.8% of debt investments at fair value, versus 10 investments and 3.0% at September 30, 2025.
- Liquidity and leverage remain within targets
- Liquidity remains meaningful, including $39.9 million of cash and cash equivalents and $659.0 million of undrawn credit-facility capacity at June 30, 2026; net debt-to-equity was 1.02x, within the 0.90x to 1.25x target range.
- Portfolio rotation generated more proceeds than funding
- The company deployed capital actively, funding $747.9 million of investments over the first nine months while receiving $775.4 million from prepayments, exits, paydowns and sales; it exited 26 portfolio companies.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Realized losses rose materially
- Realized investment losses accelerated sharply to $49.5 million in Q3 FY2026 from $13.4 million in Q3 FY2025, largely related to exits and restructurings. The quarter's $48.2 million of unrealized appreciation largely offset this, but included $52.5 million tied to exited investments and was partly offset by $5.2 million of equity depreciation.
- Portfolio value declined amid credit marks
- Portfolio fair value fell to $2.742 billion at June 30, 2026 from $2.848 billion at September 30, 2025, primarily due to realized and unrealized losses. For the nine-month period, debt investments recorded $59.9 million of net unrealized depreciation and equity investments recorded $36.5 million.
- Lower rates pressure net investment income
- Earnings remain exposed to falling benchmark rates: 91.4% of debt investments at fair value were floating rate at June 30, 2026, and management estimates a 100-basis-point rate decrease would reduce annualized net assets from operations by $9.5 million, excluding incentive fees.
- Leverage and immediate funding commitments remain sizable
- Cash declined by $39.7 million in the first nine months to $39.9 million, while immediately drawable unfunded commitments were $235.4 million. Total debt outstanding was $1.451 billion at June 30, 2026.
- No formal risk-factor updates
- There were no material risk-factor changes during the three months ended June 30, 2026 versus the fiscal 2025 Form 10-K. Nevertheless, management specifically cited inflation, elevated rates, tariffs, trade disputes and geopolitical conflict as macro uncertainties.
What they said about what is next.
No quantitative earnings or revenue outlook was provided in the 10-Q. Management said it believes liquidity is sufficient for market opportunities, with $659.0 million of undrawn credit-facility capacity as of June 30, 2026. The Board declared a future quarterly distribution of $0.30 per share plus a $0.03 supplemental distribution, payable September 30, 2026.
The filing reads worse than the one before it.
What came before.
- 10-Q · May 4, 2026
- Oaktree Specialty Lending Corporation (OCSL) reported a decrease in total investment income to $70.4 million for Q2 FY2026, down 9.3% from $77.6 million in Q2 FY2025, primarily due to lower interest income stemming from…
- 10-Q · February 4, 2026
- OCSL reported total investment income of $75,096,000 in Q1 (Dec 31, 2025) versus $86,647,000 in the year-ago quarter, and GAAP earnings per share of $0.06 (vs $0.09 prior year). Net investment income declined to…
- 10-Q · February 4, 2025
- Oaktree Specialty Lending reported total investment income of $86,647,000 for the three months ended December 31, 2024, down from $97,985,000 in the year-ago quarter (a decline of $11,338,000, -11.6%). Net investment…
- 10-Q · August 1, 2024
- Oaktree Specialty Lending reported total investment income of $94,966,000 for Q3 (three months ended June 30, 2024), down from $101,900,000 a year earlier. Net investment income was $44,575,000 ($0.54 per share) but…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing OCSL makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever